Atracurium is a non-depolarizing neuromuscular blocking agent widely used during surgical procedures to induce muscle relaxation. It acts by competitively inhibiting acetylcholine at the neuromuscular junction without causing sedation or analgesia. Maintaining the pharmaceutical purity of Atracurium is essential to ensure patient safety, drug efficacy, and adherence to regulatory standards. Impurity profiling is crucial for detecting and controlling unwanted by-products that may form during its synthesis, handling, or storage. Here are some of its known impurities listed below.
Showing 1 - 3 of 3 products
Catalogue No : ATRA-OCL-001
CAS No : 64228-81-5
In Stock
Synonyms
Mixture of the cis-cis, cis-trans and trans-trans isomers of 2,2'-[Pentane-1,5-diylbis[oxy(3-oxopropane-1,3-diyl)]]bis[1-(3,4-dimethoxybenzyl)-6,7-dim...More Detail
Mixture of the cis-cis, cis-trans and trans-trans isomers of 2,2'-[Pentane-1,5-diylbis[oxy(3-oxopropane-1,3-diyl)]]bis[1-(3,4-dimethoxybenzyl)-6,7-dim...More Detail
Catalogue No : ATRA-OCL-002
CAS No : 1699-51-0
In Stock
Synonyms
1-(3,4-Dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline
1-(3,4-Dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline
Catalogue No : ATRA-OCL-003
CAS No : 80-18-2
In Stock
Synonyms
Benzenesulfonic Acid Methyl Ester ;
Benzenesulfonic Acid Methyl Ester ;